Azzad Asset Management Inc /Adv Amgen Inc Transaction History

Azzad Asset Management Inc /Adv

$849 Billion
Q1 2025

A detailed history of Azzad Asset Management Inc /Adv transactions in Amgen Inc stock. As of the latest transaction made, Azzad Asset Management Inc /Adv holds 9,259 shares of AMGN stock, worth $2.74 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

9,259

Previous 9,087 1.89%

Holding current value

$2.74 Million

Previous $2.37 Billion 21.8%

% of portfolio

0.34%

Previous 0.46%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 Apr 16, 2025	BUY	$258.59 - $327.36 $44,477 - $56,305	172 Added 1.89%	9,259 $2.88 Billion
Q4 2024 Feb 27, 2025	BUY	$258.78 - $328.31 $2.35 Million - $2.98 Million	9,087 New	9,087 $2.37 Billion
Q3 2024 Oct 07, 2024	BUY	$309.38 - $337.38 $855,745 - $933,193	2,766 Added 44.92%	8,923 $2.87 Billion
Q2 2024 Jul 30, 2024	BUY	$262.75 - $319.31 $1.62 Million - $1.97 Million	6,157 New	6,157 $1.92 Billion
Q3 2023 Apr 01, 2024	SELL	$218.65 - $271.46 $1.57 Million - $1.95 Million	-7,188 Closed	0 $0
Q2 2023 Apr 01, 2024	BUY	$214.27 - $253.37 $35,568 - $42,059	166 Added 2.36%	7,188 $1.6 Billion
Q1 2023 Apr 01, 2024	BUY	$225.79 - $275.2 $21,224 - $25,868	94 Added 1.36%	7,022 $1.7 Billion
Q4 2022 Apr 01, 2024	SELL	$229.03 - $291.01 $2.11 Million - $2.68 Million	-9,217 Reduced 57.09%	6,928 $1.82 Billion
Q3 2022 Apr 01, 2024	BUY	$224.46 - $253.15 $30,302 - $34,175	135 Added 0.84%	16,145 $3.73 Billion
Q2 2022 Apr 01, 2024	BUY	$230.71 - $256.74 $2.13 Million - $2.38 Million	9,253 Added 136.94%	16,010 $3.83 Billion
Q1 2022 Apr 01, 2024	BUY	$219.27 - $242.57 $256,984 - $284,292	1,172 Added 20.98%	6,757 $1.63 Billion
Q4 2021 Apr 01, 2024	SELL	$198.88 - $227.6 $1.53 Million - $1.75 Million	-7,703 Reduced 57.97%	5,585 $1.26 Billion
Q3 2021 Apr 01, 2024	BUY	$212.27 - $248.7 $128,423 - $150,463	605 Added 4.77%	13,288 $2.83 Billion
Q2 2021 Apr 01, 2024	BUY	$233.58 - $259.14 $78,015 - $86,552	334 Added 2.7%	12,683 $3.09 Billion
Q1 2021 Apr 01, 2024	BUY	$221.91 - $258.6 $67,460 - $78,614	304 Added 2.52%	12,349 $3.07 Billion
Q4 2020 Apr 01, 2024	BUY	$216.38 - $257.67 $288,650 - $343,731	1,334 Added 12.45%	12,045 $2.77 Billion
Q3 2020 Apr 01, 2024	BUY	$234.65 - $260.95 $366,757 - $407,864	1,563 Added 17.09%	10,711 $2.72 Billion
Q2 2020 Apr 01, 2024	BUY	$197.81 - $242.74 $601,540 - $738,172	3,041 Added 49.8%	9,148 $2.16 Billion
Q1 2020 Apr 01, 2024	SELL	$182.24 - $241.7 $1.63 Million - $2.16 Million	-8,957 Reduced 59.46%	6,107 $1.24 Billion
Q4 2019 Apr 01, 2024	BUY	$189.21 - $243.2 $32,165 - $41,344	170 Added 1.14%	15,064 $3.58 Billion
Q3 2019 Apr 01, 2024	BUY	$174.11 - $208.62 $1.63 Million - $1.96 Million	9,389 Added 170.55%	14,894 $3.27 Billion
Q2 2019 Apr 01, 2024	BUY	$166.7 - $195.41 $263,052 - $308,356	1,578 Added 40.18%	5,505 $1.01 Billion
Q1 2019 Apr 01, 2024	SELL	$180.87 - $203.88 $2,170 - $2,446	-12 Reduced 0.3%	3,927 $746 Million
Q4 2018 Apr 01, 2024	BUY	$178.4 - $208.25 $702,717 - $820,296	3,939 New	3,939 $767 Million

Others Institutions Holding AMGN

# of Institutions

3,310

Shares Held

429M

Call Options Held

8.06M

Put Options Held

7.7M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.

Account

Azzad Asset Management Inc /Adv Amgen Inc Transaction History